Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Enzymatica

1,95 SEK

+1,57 %

Mindre end 1K følgere

ENZY

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
+1,57 %
+0,26 %
-18,28 %
-33,39 %
+23,10 %
+19,33 %
-47,42 %
-89,53 %
-65,95 %

Enzymatica is a life science company that develops and sells medical devices against infectious diseases. The products are based on barrier technology, which includes marine enzymes. The company's first product is ColdZyme® Mouth Spray, which can prevent colds and shorten the duration of the illness. The product has been launched in several markets and the strategy is to expand to more markets through partners. The head office is located in Lund.

Læs mere
Markedsværdi
472,12 mio. SEK
Aktieomsætning
56,07 t SEK
Omsætning
45,58 mio.
EBIT %
-114,22 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
18.2
2026

Årsrapport '25

28.4
2026

Delårsrapport Q1'26

7.5
2026

Generalforsamling '26

Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Pressemeddelelse26.11.2025, 09.46

BioStock: Enzymatica enters partnership with the UK Sports Institute to strengthen elite athlete health

Enzymatica
Pressemeddelelse20.11.2025, 07.30

Enzymatica AB: Enzymatica enters partnership with the UK Sports Institute to support athlete health and performance

Enzymatica
Pressemeddelelse4.11.2025, 14.13

BioStock: Enzymatica’s CEO steps down after four years – summarizes a journey from science to commercialization

Enzymatica

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse30.10.2025, 07.30

Enzymatica AB: Quarterly report Q3/2025: Strong development in Sweden and continued focus on international expansion

Enzymatica
Pressemeddelelse15.10.2025, 07.17

BioStock: Enzymatica launches new ColdZyme flavour

Enzymatica
Pressemeddelelse14.10.2025, 07.25

Enzymatica AB: ColdZyme launches a refreshing new flavour - Eucalyptus

Enzymatica
Selskabsmeddelelse13.10.2025, 08.00

Enzymatica AB: Enzymatica appoints Holger Lembrér as new CFO

Enzymatica
Pressemeddelelse1.10.2025, 11.00

Enzymatica AB: Enzymatica to Support Swedish Biathlon Federation as Official Supplier

Enzymatica
Selskabsmeddelelse22.8.2025, 11.50

Bulletin from the Extraordinary General Meeting of Enzymatica AB (publ) on 22 August 2025

Enzymatica
Selskabsmeddelelse12.8.2025, 06.00

Sana Alajmovic appointed new CEO of Enzymatica AB

Enzymatica
Selskabsmeddelelse6.8.2025, 06.30

Notice of Extraordinary General Meeting in Enzymatica AB (publ)

Enzymatica
Selskabsmeddelelse17.7.2025, 06.30

Enzymatica AB: Quarterly report Q2/2025: Strong development in Sweden and increased international activity

Enzymatica
Pressemeddelelse14.7.2025, 14.32

BioStock: Enzymatica’s CEO comments on his resignation

Enzymatica
Pressemeddelelse30.6.2025, 06.15

Enzymatica AB: Enzymatica's CFO Therese Filmersson to leave her position

Enzymatica
Selskabsmeddelelse26.6.2025, 10.15

Enzymatica AB: Claus Egstrand steps down as CEO of Enzymatica

Enzymatica
Pressemeddelelse14.5.2025, 13.10

BioStock: The science behind ColdZyme – Insights from professors

Enzymatica
Selskabsmeddelelse7.5.2025, 13.44

Bulletin from the annual general meeting of Enzymatica AB (publ) on May 7, 2025

Enzymatica
Pressemeddelelse5.5.2025, 09.15

Enzymatica AB: BioStock: Enzymatica gears up for global expansion after a strong first quarter

Enzymatica
Selskabsmeddelelse29.4.2025, 06.30

Enzymatica AB: Quarterly report Q1/2025: Enzymatica strengthens its position in home markets and focuses on international expansion

Enzymatica
Selskabsmeddelelse2.4.2025, 12.45

Notice of Annual General Meeting 2025 in Enzymatica AB (publ)

Enzymatica
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.